Showing 241 - 260 results of 31,560 for search '(( 50 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ) OR ( a step decrease ))', query time: 0.82s Refine Results
  1. 241

    Features and Consequences of Isopropanol Burning off PTFE–rGO Aerogels by Sergey A. Baskakov (11324315)

    Published 2021
    “…An improved procedure for the preparation of aerogel granules of polytetrafluoroethylene–graphene oxide (PTFE–GO) with a composition of 50:50 (in wt %) and a specific density of 35 ± 2 mg/cm<sup>3</sup> is described. …”
  2. 242
  3. 243
  4. 244

    Topography of the relationship between the change in alpha power decrease and the change in M50 gating ratio. by Tzvetan Popov (315385)

    Published 2013
    “…B: Relationship between change in alpha power decrease (abscissa, negative values indicate improvement) and pre-to-post-training change in M50 gating ratio (ordinate, positive values indicate changes towards normal, that is, smaller gating ratio) by patient training group based on the ROI in 4A.…”
  5. 245

    Autocorrelation of walking speed, step length and step width as a function of lag in steps. by Steven H. Collins (253107)

    Published 2013
    “…Total step length autocorrelation also exhibits a long-term trend, whereas de-trended step length has an autocorrelation resembling white noise. …”
  6. 246
  7. 247
  8. 248

    Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
  9. 249

    Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

    Published 2025
    “…The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …”
  10. 250
  11. 251
  12. 252
  13. 253
  14. 254

    Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study by Asita Wongprikorn (2837378)

    Published 2016
    “…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
  15. 255
  16. 256
  17. 257
  18. 258
  19. 259
  20. 260